Aletaha, D. & Smolen, J. S. Prognosis and administration of rheumatoid arthritis: a evaluate. JAMA 320, 1360–1372 (2018).
Gravallese, E. M. & Firestein, G. S. Rheumatoid arthritis—widespread origins, divergent mechanisms. N. Engl. J. Med. 388, 529–542 (2023).
Zhang, F. et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature 623, 616–624 (2023).
Fearon, U., Hanlon, M. M., Floudas, A. & Veale, D. J. Mobile metabolic variations in rheumatoid arthritis and their therapeutic implications. Nat. Rev. Rheumatol. 18, 398–414 (2022).
Buckley, C. D., Ospelt, C., Homosexual, S. & Midwood, Ok. S. Location, location, location: how the tissue microenvironment impacts irritation in RA. Nat. Rev. Rheumatol. 17, 195–212 (2021).
Weyand, C. M. & Goronzy, J. J. Immunometabolism in early and late phases of rheumatoid arthritis. Nat. Rev. Rheumatol. 13, 291–301 (2017).
Boutet, M. A. et al. Novel insights into macrophage range in rheumatoid arthritis synovium. Autoimmun. Rev. 20, 102758 (2021).
Martel-Pelletier, J. et al. Osteoarthritis. Nat. Rev. Dis. Prim. 2, 16072 (2016).
Burmester, G. R. & Pope, J. E. Novel remedy methods in rheumatoid arthritis. Lancet 389, 2338–2348 (2017).
Nissen, S. E. et al. Cardiovascular security of celecoxib, naproxen, or ibuprofen for arthritis. N. Engl. J. Med. 375, 2519–2529 (2016).
Erhardt, D. P. et al. Low persistence charges in sufferers with rheumatoid arthritis handled with triple remedy and antagonistic drug occasions related to sulfasalazine. Arthritis Care Res. 71, 1326–1335 (2019).
Zhu, Y. et al. Rheumatoid arthritis microenvironment insights into remedy impact of nanomaterials. Nano In the present day 42, 101358 (2022).
Nizet, V. & Johnson, R. S. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9, 609–617 (2009).
Zhao, Y. et al. Nanozyme-reinforced hydrogel as a H2O2-driven oxygenerator for enhancing prosthetic interface osseointegration in rheumatoid arthritis remedy. Nat. Commun. 13, 6758 (2022).
Zhang, Q. et al. Neutrophil membrane-coated nanoparticles inhibit synovial irritation and alleviate joint injury in inflammatory arthritis. Nat. Nanotechnol. 13, 1182–1190 (2018).
Jia, M. et al. Messenger nanozyme for reprogramming the microenvironment of rheumatoid arthritis. ACS Appl. Mater. Interfaces 15, 338–353 (2023).
Kim, J. et al. Synergistic oxygen technology and reactive oxygen species scavenging by manganese ferrite/ceria co-decorated nanoparticles for rheumatoid arthritis remedy. ACS Nano 13, 3206–3217 (2019).
Yang, Y. et al. Focused silver nanoparticles for rheumatoid arthritis remedy by way of macrophage apoptosis and re-polarization. Biomaterials 264, 120390 (2021).
Yang, J., Yang, B. & Shi, J. A nanomedicine-enabled ion-exchange technique for enhancing curcumin-based rheumatoid arthritis remedy. Angew. Chem. Int. Ed. 62, e202310061 (2023).
Xu, C. et al. Arthritic microenvironment actuated nanomotors for lively rheumatoid arthritis remedy. Adv. Sci. 10, e2204881 (2023).
Chen, J. et al. Photoacoustic image-guided biomimetic nanoparticles concentrating on rheumatoid arthritis. Proc. Natl Acad. Sci. USA 119, e2213373119 (2022).
Koo, S. et al. Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis mannequin. Nat. Nanotechnol. 18, 1502–1514 (2023).
Del Giudice, G. et al. An ancestral molecular response to nanomaterial particulates. Nat. Nanotechnol. 18, 957–966 (2023).
Stater, E. P., Sonay, A. Y., Hart, C. & Grimm, J. The ancillary results of nanoparticles and their implications for nanomedicine. Nat. Nanotechnol. 16, 1180–1194 (2021).
Gao, J. et al. Intracerebral destiny of natural and inorganic nanoparticles depends on microglial extracellular vesicle operate. Nat. Nanotechnol. 19, 376–386 (2024).
Li, Y. et al. Innate immunity-modulating nanobiomaterials for controlling irritation decision. Matter 7, 3811–3844 (2024).
Zhang, M. et al. Edible ginger-derived nanoparticles: a novel therapeutic strategy for the prevention and remedy of inflammatory bowel illness and colitis-associated most cancers. Biomaterials 101, 321–340 (2016).
Chen, Q. et al. Pure exosome-like nanovesicles from edible tea flowers suppress metastatic breast most cancers by way of ROS technology and microbiota modulation. Acta Pharm. Sin. B 12, 907–923 (2022).
Feng, T., Ahmed, W., Ahmed, T. & Chen, L. Nanoparticles derived from natural preparations might characterize a novel nucleic acid remedy. Interdiscip. Med. 2, e20230029 (2024).
Miller, T. E. et al. Gentle-powered CO2 fixation in a chloroplast mimic with pure and artificial elements. Science 368, 649–654 (2020).
Gao, F. et al. Synthetic photosynthetic cells with biotic–abiotic hybrid vitality modules for custom-made CO2 conversion. Nat. Commun. 14, 6783 (2023).
Hou, L. et al. Hybrid-membrane-decorated Prussian blue for efficient most cancers immunotherapy by way of tumor-associated macrophages polarization and hypoxia reduction. Adv. Mater. 34, e2200389 (2022).
Suk, J. S., Xu, Q., Kim, N., Hanes, J. & Ensign, L. M. PEGylation as a method for bettering nanoparticle-based drug and gene supply. Adv. Drug Deliv. Rev. 99, 28–51 (2016).
Kobayashi, Ok., Jimbo, H., Nakamura, Y. & Wada, H. Biosynthesis of phosphatidylglycerol in photosynthetic organisms. Prog. Lipid Res. 93, 101266 (2024).
Pali, T., Garab, G., Horvath, L. I. & Kota, Z. Practical significance of the lipid-protein interface in photosynthetic membranes. Cell. Mol. Life Sci. 60, 1591–1606 (2003).
Liu, J. et al. Supply of biomimetic liposomes by way of meningeal lymphatic vessels route for focused remedy of Parkinson’s illness. Analysis 6, 0030 (2023).
Hao, M. et al. Mixture of metabolic intervention and T cell remedy enhances stable tumor immunotherapy. Sci. Transl. Med. 12, eaaz6667 (2020).
Barber, J. A mechanism for water splitting and oxygen manufacturing in photosynthesis. Nat. Crops 3, 17041 (2017).
Kafri, M. et al. Systematic identification and characterization of genes within the regulation and biogenesis of photosynthetic equipment. Cell 186, 5638–5655.25 (2023).
Hald Albertsen, C. et al. The function of lipid elements in lipid nanoparticles for vaccines and gene remedy. Adv. Drug Deliv. Rev. 188, 114416 (2022).
Chen, P. et al. A plant-derived pure photosynthetic system for bettering cell anabolism. Nature 612, 546–554 (2022).
Alivernini, S. et al. Distinct synovial tissue macrophage subsets regulate irritation and remission in rheumatoid arthritis. Nat. Med. 26, 1295–1306 (2020).
Smolen, J. S. et al. Rheumatoid arthritis. Nat. Rev. Dis. Prim. 4, 18001 (2018).
Lan, R. et al. Folate receptor-targeted NIR-II dual-model nanoprobes for multiscale visualization of macrophages in rheumatoid arthritis. Adv. Func. Mat. 33, 2300342 (2023).
Ma, Y. et al. DNA origami as a nanomedicine for focused rheumatoid arthritis remedy by reactive oxygen species and nitric oxide scavenging. ACS Nano 16, 12520–12531 (2022).
Hegarty, L. M., Jones, G. R. & Bain, C. C. Macrophages in intestinal homeostasis and inflammatory bowel illness. Nat. Rev. Gastroenterol. Hepatol. 20, 538–553 (2023).
Venkatesan, R. et al. Immuno-modulating theranostic gold nanocages for the remedy of rheumatoid arthritis in vivo. Chem. Eng. J. 446, 136868 (2022).
Tardito, S. et al. Macrophage M1/M2 polarization and rheumatoid arthritis: a scientific evaluate. Autoimmun. Rev. 18, 102397 (2019).
Liu, Y. et al. Multifunctional Janus nanoplatform for effectively synergistic theranostics of rheumatoid arthritis. ACS Nano 17, 8167–8182 (2023).
You, D. G. et al. Metabolically engineered stem cell–derived exosomes to manage macrophage heterogeneity in rheumatoid arthritis. Sci. Adv. 7, eabe0083 (2021).
Rodriguez-Ramiro, I. et al. Pharmacological and genetic will increase in liver NADPH ranges ameliorate NASH development in feminine mice. Free Radic. Biol. Med. 210, 448–461 (2024).
Weng, L. et al. Surplus fatty acid synthesis will increase oxidative stress in adipocytes and lnduces lipodystrophy. Nat. Commun. 15, 133 (2024).
Fearon, U., Canavan, M., Biniecka, M. & Veale, D. J. Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis. Nat. Rev. Rheumatol. 12, 385–397 (2016).
Jia, N. et al. Metabolic reprogramming of proinflammatory macrophages by goal delivered roburic acid successfully ameliorates rheumatoid arthritis signs. Sign Transduct. Goal Ther. 8, 280 (2023).
Guan, F. et al. Tissue macrophages: origin, heterogenity, organic capabilities, illnesses and therapeutic targets. Sign Transduct. Goal Ther. 10, 93 (2025).
Wang, Z. et al. A focused exosome therapeutic confers each CfDNA scavenging and macrophage polarization for ameliorating rheumatoid arthritis. Adv. Mater. 35, e2302503 (2023).
Li, L. et al. M2 macrophage-derived sEV regulate pro-inflammatory CCR2+ macrophage subpopulations to favor post-AMI cardiac restore. Adv. Sci. 10, e2202964 (2023).
Qiao, Y. et al. Engineered algae: a novel oxygen-generating system for efficient remedy of hypoxic most cancers. Sci. Adv. 6, eaba5996 (2020).
Wang, W. et al. Engineering micro oxygen factories to sluggish tumour development by way of hyperoxic microenvironments. Nat. Commun. 13, 4495 (2022).
Zhong, D. et al. Microalgae-based hydrogel for inflammatory bowel illness and its related nervousness and melancholy. Adv. Mater. 36, e2312275 (2024).
Ouyang, J. et al. Biomimetic nanothylakoids for environment friendly imaging-guided photodynamic remedy for most cancers. Chem. Commun. 54, 3468–3471 (2018).
Chen, B., Ni, Y., Liu, J., Zhang, Y. & Yan, F. Bone marrow-derived mesenchymal stem cells exert various results on totally different macrophage subsets. Stem Cells Int. 2018, 8348121 (2018).
Wynn, T. A., Chawla, A. & Pollard, J. W. Macrophage biology in improvement, homeostasis and illness. Nature 496, 445–455 (2013).
Ma, C. et al. Considerably bettering the bioefficacy for rheumatoid arthritis with supramolecular nanoformulations. Adv. Mater. 33, e2100098 (2021).